Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2010 Apr 15;140(2):440–446. doi: 10.1016/j.jtcvs.2010.03.002

Table 3. Pulmonary inflammation at the end of the 120-min reperfusion period.

Group TNF-α (pg/ml) MPO Activity (ΔOD/g/min) Wet/Dry Weight
Control 1336 ± 18.9 0.858 ± 0.012 3.07 ± 0.08
A1 agonist 759 ± 14.7 a, b 0.582 ± 0.013 a, b 2.22 ± 0.05 a
A1 agonist + antagonist 1308 ± 18.7 b 0.810 ± 0.015 b 2.98 ± 0.09 b
A2A agonist 804 ± 17.6 a, b 0.482 ± 0.017 a, b, c 2.08 ± 0.05 a
A2A agonist + antagonist 1326 ± 18.7 b 0.847 ± 0.026 b 2.90 ± 0.18 b
A3 agonist 778 ± 10.5 a, b 0.540 ± 0.016 a, b 2.03 ± 0.08 a
A3 agonist + antagonist 1287 ± 13.8 b 0.843 ± 0.150 b 3.00 ± 0.06 b
Adenosine 978 ± 26.0 a 0.697 ± 0.028 a 2.41 ± 0.06 a
a

p<0.0002 vs. Control,

b

p<0.01 vs. Adenosine,

c

p<0.01 vs. A1 agonist